Transcutaneous electrical stimulation in chronic post-stroke oropharyngeal dysphagia: pooled biomechanical and kinematic analysis from a one-year randomized controlled clinical trial


Por: Ortega, O, Palomeras, E and Clavé, P

Publicada: 10 jul 2025 Ahead of Print: 10 jul 2025
Resumen:
Oropharyngeal dysphagia in chronic post-stroke (PS-OD) patients is associated with impaired oropharyngeal sensory/motor function. We aimed to evaluate the effect of transcutaneous electrical stimulation (TES) on the biomechanics and kinetics of swallowing in PS-OD patients in a randomized controlled clinical trial with 1-year follow-up. 71 PS-OD patients with impaired safety of swallow (ISS) were randomized into 2 groups, (1) 26 with compensatory treatment (CT): thickeners and texture-modified diets, and (2) 45 with active treatment (TES + CT) with 2 cycles of TES (VitalStim; Enovis, USA), at baseline and 6 months. Each TES cycle consisted of 15 1-hour sessions over 2 weeks. Its effect was assessed by videofluoroscopy (baseline, post-treatment 1, 6 months, post-treatment 2, 12 months). Both groups were homogeneous, patients had 74.41 +/- 11.28 years (31.00% women), functional decline (Barthel 72 +/- 31), comorbidities (Charlson 3.00 +/- 1.57), nutritional risk (MNA-sf 10.29 +/- 2.59) and moderate stroke (NIHSS 3.35 +/- 4.01). All had ISS (penetration-aspiration scale [PAS] 4.61 +/- 1.67, only 9.86% could swallow thin liquid safely) and biomechanical delay (time to laryngeal vestibular closure [LVC] 402.82 +/- 111.98ms). Swallowing parameters improved significantly between baseline and 12 months in the TES group (ISS, p < 0.001; PAS, safe thin liquid hydration, LVC, p < 0.0001; bolus kinematics, p < 0.05). No changes were observed in hyoid bone movement or timing. The CT group did not show any significant biomechanical changes. No relevant adverse events were associated with TES. TES is a safe and effective therapy for PS-OD. After 1 year of follow up, it improved ISS, time to LVC, bolus kinetics, and reduced the need for thickening agents.

Filiaciones:
:
 Univ Autonoma Barcelona, Hosp Univ Mataro, Gastrointestinal Physiol Lab, CIBERehd,CSdM,UAB, Carretera Cirera 230, Mataro 08304, Barcelona, Spain

 Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain

Palomeras, E:
 Hosp Univ Mataro, Neurol Dept, Consorci Sanitari Maresme, Mataro, Spain

:
 Univ Autonoma Barcelona, Hosp Univ Mataro, Gastrointestinal Physiol Lab, CIBERehd,CSdM,UAB, Carretera Cirera 230, Mataro 08304, Barcelona, Spain

 Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain
ISSN: 20452322





Scientific Reports
Editorial
Nature Publishing Group, HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY, Reino Unido
Tipo de documento: Article
Volumen: 15 Número: 1
Páginas: 24903-24903
WOS Id: 001527009000038
ID de PubMed: 40640318
imagen Green Submitted, gold

MÉTRICAS